<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
PANW, AMAT, GPS...
11/18/2022 16:11pm
What You Missed On Wall Street On Friday

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

  • Palo Alto Networks (PANW) reported better-than-expected Q1 results and provided upbeat guidance for Q2 and FY23 [more]
  • Applied Materials (AMAT) reported better-than-expected Q4 results [more]
  • Gap (GPS) reported upbeat Q3 results [more]
  • Grindr (GRND) completed its business combination and jumped after it began trading on the NYSE [more]
  • Honeywell (HON) announced a $1.325B agreement with the North American Refractories Asbestos Personal Injury Settlement Trust [more]

2. WALL STREET CALLS:

  • Coinbase (COIN) downgraded to Neutral at BofA amid clouds from FTX fallout [more]
  • HP Inc. (HPQ) downgraded to Neutral from Outperform at Credit Suisse [more]
  • Walgreens Boots Alliance (WBA) upgraded to Overweight from Neutral at JPMorgan [more]
  • DraftKings (DKNG) initiated with an Overweight at Piper Sandler [more]
  • Oppenheimer and Credit Suisse downgraded Editas Medicine (EDIT) to Neutral or equivalent ratings following news that the Phase 1/2 BRILLIANCE trial of EDIT-101 for Leber congenital amaurosis 10 is pausing enrollment following preliminary efficacy data [more]

3. AROUND THE WEB:

  • JPMorgan (JPM) is launching a national program to expand small business lending, WSJ reports [more]
  • Masayoshi Son owes nearly $5B to SoftBank (SFTBY), FT reports [more]
  • Carvana (CVNA) laying off 8% of workforce, CNBC's Scott Wapner reports [more]
  • Google (GOOG) is alleged to have agreed to pay 24 app developers to stop competition, Reuters reports [more]
  • The DOJ has opened an antitrust probe into Live Nation's (LYV) Ticketmaster, NY Times reports [more]

4. MOVERS:

  • Iveric bio (ISEE) higher after the FDA granted breakthrough designation for Zimura [more]
  • Apellis Pharmaceuticals (APLS) gains after the FDA accepted its NDA amendment and a new PDUFA date was set for pegcetacoplan [more]
  • Ardelyx (ARDX) continues rise after director David Mott acquired 567,000 shares of the stock [more]
  • G1 Therapeutics (GTHX) lower after announcing a 7.7M share offering [more]
  • Farfetch (FTCH) declines in New York after reporting quarterly results [more]

5. EARNINGS/GUIDANCE:

  • JD.com (JD) reported mixed Q3 results [more]
  • Foot Locker (FL) provided a "beat and raise" report for Q3 [more]
  • Ross Stores (ROST) provided a "beat and raise" report for Q3 [more]
  • Spectrum Brands (SPB) reported downbeat Q4 results [more]
  • Williams-Sonoma (WSM) reported better-than-expected Q3 results [more]

INDEXES:

The Dow rose 199.37, or 0.59%, to 33,745.69, the Nasdaq gained 1.10, or 0.0099%, to 11,146.06, and the S&P 500 advanced  18.78, or 0.48%, to 3,965.34.

dynamic_feed Breaking News